Coherus Oncology Inc (CHRS)

Total Costs & Expenses

$207.53M

TTM · Period ending: · USD

CHRS logo

CHRS Total Costs & Expenses

Latest reported$207.53M
CHRS TTM Total Costs & Expenses ($37.59M → $207.53M)
High-resolution chart · PNG

CHRS total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Coherus Oncology Inc Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
207,531,000
216,633,000
221,206,000
258,968,000
282,325,000
312,073,000
329,134,000
393,173,000
422,586,000
430,357,000
460,443,000
396,859,000
416,158,000
427,063,000
467,922,000
483,995,000
473,412,000
481,055,000
590,409,000
571,485,000
536,030,000
494,587,000
319,505,000
304,334,000
284,342,000
269,918,000
248,303,000
229,982,000
227,111,000
216,081,000
204,416,000
190,380,000
190,023,000
203,146,000
233,692,000
261,530,000
283,133,000
301,904,000
306,037,000
294,138,000
294,304,000
283,261,000
249,108,000
219,756,000
163,847,000
120,989,000
95,788,000
74,454,000
59,268,000
45,581,000
37,592,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.